GPER1 and breast cancer: Upregulation of GPR30 expression was observed following tamoxifen treatment in a small BC cohort [21], and GPR30 expression was associated with worse prognosis for BC patients treated with tamoxifen as compared to tamoxifen-naïve patients [24].